Interleukin-21 as a new therapeutic target for immune-mediated diseases.
Trends Pharmacol Sci. 2009 Aug;30(8):441-7. doi: 10.1016/j.tips.2009.05.006. Epub 2009 Jul 16.
Trends Pharmacol Sci. 2009.
PMID: 19616319
Review.